Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature.
about
Effectiveness of a simple lymphoedema treatment regimen in podoconiosis management in southern ethiopia: one year follow-upThe economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007)Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New GuineaRepurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasisBurden assessment of podoconiosis in Wayu Tuka woreda, east Wollega zone, western Ethiopia: a community-based cross-sectional studyMarriage, sex, and hydrocele: an ethnographic study on the effect of filarial hydrocele on conjugal life and marriageability from Orissa, India.Feasibility and effectiveness of basic lymphedema management in Leogane, Haiti, an area endemic for bancroftian filariasis.Investment Success in Public Health: An Analysis of the Cost-Effectiveness and Cost-Benefit of the Global Programme to Eliminate Lymphatic Filariasis.Enhancing genome investigations in the mosquito Culex quinquefasciatus via BAC library construction and characterization.The emerging story of disability associated with lymphatic filariasis: a critical reviewThe 6th Meeting of the Global Alliance to Eliminate Lymphatic Filariasis: A half-time review of lymphatic filariasis elimination and its integration with the control of other neglected tropical diseases.Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration.Impact of community-based lymphedema management on perceived disability among patients with lymphatic filariasis in Orissa State, India.A qualitative study exploring barriers related to use of footwear in rural highland ethiopia: implications for neglected tropical disease control.Health-seeking behaviors and self-care practices of people with filarial lymphoedema in Nepal: a qualitative studyThe Global Programme to Eliminate Lymphatic Filariasis: History and achievements with special reference to annual single-dose treatment with diethylcarbamazine in Samoa and FijiSurgical Treatment of Genital Manifestations of Lymphatic Filariasis: A Systematic Review.Experiences of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India: An Analysis of Focus Group Discussions with Patients, Families, Community Members and Program VolunteersPreventive Chemotherapy Versus Innovative and Intensified Disease Management in Neglected Tropical Diseases: A Distinction Whose Shelf Life Has Expired.Evaluating the Burden of Lymphedema Due to Lymphatic Filariasis in 2005 in Khurda District, Odisha State, India.Doxycycline improves filarial lymphedema independent of active filarial infection: a randomized controlled trial.Transmission indices and microfilariae prevalence in human population prior to mass drug administration with ivermectin and albendazole in the Gomoa District of Ghana.The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000-2014).Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India.A longitudinal analysis of the effect of mass drug administration on acute inflammatory episodes and disease progression in lymphedema patients in Leogane, Haiti.Current practices in the management of lymphatic filariasis.Current Epidemiological Assessment of Bancroftian Filariasis in Tanga Region, Northeastern Tanzania.The use of focus groups to develop a culturally relevant quality of life tool for lymphatic filariasis in BangladeshMeasuring the physical and economic impact of filarial lymphoedema in Chikwawa district, Malawi: a case-control study.Non-endemic cases of lymphatic filariasis.Impact of basic lymphedema management and antifilarial treatment on acute dermatolymphangioadenitis episodes and filarial antigenaemia.Lymphatic filariasis patient identification in a large urban area of Tanzania: An application of a community-led mHealth system.Assessing numbers and faces: a prerequisite for improving access to lymphatic filariasis morbidity care.Situational analysis of lymphatic filariasis morbidity in Ahanta West District of Ghana.Clinical case estimates of lymphatic filariasis in an endemic district of Bangladesh after a decade of mass drug administration.Exploring hydrocoele surgery accessibility and impact in a lymphatic filariasis endemic area of southern Malawi.The stigmata and discrimination experienced, in southern India, by cases of lymphatic filariasis.Preventing cellulitis: where next?Global surgery and the neglected tropical diseases.Lymphatic filariasis: patients and the global elimination programme.
P2860
Q28300723-080C31D2-21B0-4B83-A88C-8722A09403ADQ28474146-D98F207B-B3EA-4C63-BDDA-A382D4EBDB32Q28478979-9E37FC0E-8FE9-435B-9E6A-A7C5CF7742C0Q28543559-075227E9-BA19-4672-8C6B-BB76C50A44B0Q28597945-62D81798-8A6C-416A-8132-AA39E1507F09Q33432756-59CE5773-FB55-4DC1-A757-5AA4DB028513Q33565637-D4F5D235-11B7-4A7B-8D85-0878B50D96ECQ33603042-FF236E79-4B71-4F07-8F47-4B37E52F08E8Q34018481-5BC645B5-F9AE-4BBD-8947-8E810FCAA413Q34117948-0466490A-4715-453F-9C68-FB069853698CQ34322310-D3A53539-71F9-408D-895B-16ACE12BD4D1Q34517923-15B0D04E-27F4-4714-9405-42B734CA27A8Q34630523-06628ED5-FA3C-44DA-85C1-DBE69119CC05Q34702602-0A2ED8C5-0D2D-43E1-9776-5389F6F75777Q35074397-D1B2F3B3-85AF-4D67-B695-A77CAEDE6D3AQ35325544-06320C69-EF48-4A2A-8F83-5D9BF49F8CCEQ35759590-6F1E3784-5966-4633-8C63-31A99CFDD3E7Q35915701-F96F12E9-23A6-4DCC-8776-D395F7D342F4Q35989698-AFDF3A54-5935-4F33-B17B-A344F03A7850Q36109094-027BF058-4DD3-4E13-AB58-F5A763258C04Q36143298-A1DCF9CC-3D5E-4C29-A25F-0CE2D234D271Q36219421-7B290A04-32E1-447C-B1F1-0532ECCD9022Q37077016-7C56C786-D888-4EEE-A642-0A9664FD460EQ37336574-FA76BDEA-D04A-4033-A0B0-0F93D4785531Q37456187-8039EFA1-BFF8-42E5-907A-ABB4B544CD42Q37503357-DB417BBC-499D-4E7D-9BC9-C931004ABEE4Q37516470-004A9FAB-C346-419E-B42F-666A4991D5E3Q37592936-85282BA6-E0A7-4D11-8CC1-398BC9D2AD32Q37733874-51F84678-A1A2-439C-8E08-CFBE482C276BQ38241993-7F0FADF2-5566-4AA4-B6EC-7E9E5B23F14DQ38265715-7B9363A5-A1C7-4158-B901-B3D4B2843D80Q38678870-C7916344-F4BF-4785-A2A9-479310B7B05FQ38899270-C47FFBE7-84C0-441E-AE7B-95B690DC9244Q38941025-39C6F0E7-9221-4E33-99FA-06BD75FA7F6AQ38953815-D74FD90A-650F-4D0E-8816-05CD43043DDEQ39486520-B6406E2B-989D-4213-93E1-6064AD9C5105Q39949198-3550A764-B53E-433C-9F92-C6BF83A2EDCFQ41591638-C141E46A-1C30-4221-996E-41F8E449BED9Q42366145-35A068A1-A7CC-4452-9550-0A081DA6BD88Q43942605-2685C335-2A2A-448C-9238-A3F4F8B6DFD1
P2860
Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Morbidity management in the Gl ...... of the scientific literature.
@ast
Morbidity management in the Gl ...... of the scientific literature.
@en
type
label
Morbidity management in the Gl ...... of the scientific literature.
@ast
Morbidity management in the Gl ...... of the scientific literature.
@en
prefLabel
Morbidity management in the Gl ...... of the scientific literature.
@ast
Morbidity management in the Gl ...... of the scientific literature.
@en
P2860
P356
P1433
P1476
Morbidity management in the Gl ...... of the scientific literature.
@en
P2093
David G Addiss
Molly A Brady
P2860
P2888
P356
10.1186/1475-2883-6-2
P577
2007-02-15T00:00:00Z
P5875
P6179
1034322699